Kerastem Receives Conditional Approval from FDA for Alopecia Trial
Kerastem Technologies announce that the Company has received notice of conditional approval from the U.S. FDA Center For Biologics Evaluation and Research (CBER) Office of Cellular, Tissue and Gene Therapies...
Read More
